22. Recommendations for use of amphotericin B preparations

For Microbiology approval / consultant use only

  1.The patient has either failed to respond after >5 days treatment on conventional amphotericin B at an appropriate dose
  2.The patient shows severe systemic side effects when treated with conventional amphotericin B
  3.The patient shows a marked degree of renal impairment (<30ml/min) - or develops renal impairment requiring          discontinuation of conventional amphotericin B
  4.The patient is being treated with other nephrotoxic agents and therefore at increased risk of nephrotoxicity from          conventional amphotericin B

      Conventional amphotericin B (Fungizone)

       Lipid-based amphotericin B formulations

       NOTE

      ABELCET (Amphotericin B Lipid Complex) is a complex of Amphotericin B with phospholipids, which forms a ribbon-like       structure

Note the different concentrations for infusion

 

AMBISOME

ABELCET

USUAL CONCENTRATION

0.2-2mg/ml

1mg/ml

MAXIMUM CONCENTRATION

2mg/ml

2mg/ml

MANUFACTURER'S DOSAGE (mg/kg/day)

3

5

LENGTH OF INFUSION (HOURS)

½ - 1

2
(2.5mg/kg/hr)

Doses above those recommended here should ONLY be prescribed on the advice of a consultant mycologist.

Additional advice

For all formulations of amphotericin.

Important
A daily review of the patient's proposed duration of treatment should take place.